Full Text View
Tabular View
No Study Results Posted
Related Studies
Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts. (ETNA)
This study is currently recruiting participants.
Study NCT00058812   Information provided by Baylor College of Medicine
First Received: April 11, 2003   Last Updated: July 30, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bone Marrow Transplantation
Epstein-Barr Virus Infections
Additional conditions recognized in this trial
Infection
Virus Diseases
More general conditions related to this trial
DNA Virus Infections
Herpesviridae Infections
Neoplasms
Neoplasms, Experimental
Tumor Virus Infections
Interventions listed in this trial
EBV specific T cells
Sponsors listed in this trial
Baylor College of Medicine
Texas Children's Hospital
The Methodist Hospital System
Center for Cell and Gene Therapy


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services